Search research articles
Contact Us
Filters
Showing results (181-190 of 216) with videos related to
Page
of 22
Sort By:
Journal of Neuropathology and Experimental Neurology
|
July 11, 2007
Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response
Riccardo Cassiani-Ingoni, Paolo A Muraro, Tim Magnus, et al.
Plos Computational Biology
|
October 27, 2017
Dynamics and heterogeneity of brain damage in multiple sclerosis
Ekaterina Kotelnikova, Narsis A Kiani, Elena Abad, et al.
The Journal of Experimental Medicine
|
March 2, 2005
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients
Paolo A Muraro, Daniel C Douek, Amy Packer, et al.
European Journal of Immunology
|
September 19, 2020
Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15
Hana Zdimerova, Anita Murer, Christine Engelmann, et al.
Plos One
|
February 9, 2017
Cystatin F is a biomarker of prion pathogenesis in mice
Mario Nuvolone, Nicolas Schmid, Gino Miele, et al.
Brain : a Journal of Neurology
|
July 19, 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
Sofia V Abrahamsson, Daniela F Angelini, Amy N Dubinsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2010
Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis
Montse Camiña-Tato, Carlos Morcillo-Suárez, Marta F Bustamante, et al.
Genome Medicine
|
July 17, 2021
Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis
Marti Bernardo-Faura, Melanie Rinas, Jakob Wirbel, et al.
Bone Marrow Transplantation
|
September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 18, 2017
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)
Klarissa Hanja Stürner, Jan-Patrick Stellmann, Jan Dörr, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 216) with videos related to
Sort By:
Page
of 22
Journal of Neuropathology and Experimental Neurology
|
July 11, 2007
Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response
Riccardo Cassiani-Ingoni, Paolo A Muraro, Tim Magnus, et al.
Plos Computational Biology
|
October 27, 2017
Dynamics and heterogeneity of brain damage in multiple sclerosis
Ekaterina Kotelnikova, Narsis A Kiani, Elena Abad, et al.
The Journal of Experimental Medicine
|
March 2, 2005
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients
Paolo A Muraro, Daniel C Douek, Amy Packer, et al.
European Journal of Immunology
|
September 19, 2020
Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15
Hana Zdimerova, Anita Murer, Christine Engelmann, et al.
Plos One
|
February 9, 2017
Cystatin F is a biomarker of prion pathogenesis in mice
Mario Nuvolone, Nicolas Schmid, Gino Miele, et al.
Brain : a Journal of Neurology
|
July 19, 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
Sofia V Abrahamsson, Daniela F Angelini, Amy N Dubinsky, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2010
Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis
Montse Camiña-Tato, Carlos Morcillo-Suárez, Marta F Bustamante, et al.
Genome Medicine
|
July 17, 2021
Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis
Marti Bernardo-Faura, Melanie Rinas, Jakob Wirbel, et al.
Bone Marrow Transplantation
|
September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 18, 2017
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)
Klarissa Hanja Stürner, Jan-Patrick Stellmann, Jan Dörr, et al.
Page
of 22